As of 2025-04-30, the Relative Valuation of Rubius Therapeutics Inc (RUBY) is (100.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 USD, the upside of Rubius Therapeutics Inc based on Relative Valuation is -121438.3%.
The range of the Relative Valuation is (82.13) - (129.82) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.4x - 44.9x | 37.9x |
| Forward P/E multiples | 24.3x - 45.7x | 31.7x |
| Fair Price | (82.13) - (129.82) | (100.71) |
| Upside | -99053.5% - -156514.9% | -121438.3% |
| Date | P/E |